Cavendish (Taizhou) Pharmaceutical

Cavendish (Taizhou) Pharmaceutical is a research-driven pharmaceutical company based in China Medical City, Taizhou. The company specializes in the development and manufacturing of high-end generic drugs and innovative small molecule therapeutics, with a primary focus on oncology, cardiovascular, and metabolic diseases. Cavendish is recognized for its strong R&D capabilities in complex chemical synthesis and has successfully brought several first-to-market generics to the Chinese market, including versions of imatinib and dasatinib. The firm operates integrated facilities that span from drug discovery and process development to commercial-scale GMP manufacturing.